stockrow
Friday 6 November 2026
Export DNLI’s income statement to Excel — free account
Denali Therapeutics Inc.
DNLI Healthcare Biotechnology
Denali Therapeutics Inc.’s revenue for fiscal 2023 (year ended December 2023) was $330.5 million, up 204.7% from fiscal 2022.
- Revenue
- −94.0%
- EPS
- +150.3%
- Free cash flow
- −11.8%
- Total debt
- −1.89%
Quarter to September 2026, against a year earlier
20.12
0.40
+2.03%
Follow DNLI
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (33.94%) | (54.93%) | (49.59%) | (45.69%) |
+8 more TTM periods Free account |
|
| (27.20%) | (44.01%) | (40.04%) | (40.69%) | ||
ROIC |
(80.00%) | (260.54%) | 0.00% | (229.23%) | |
Return on Tangible Assets |
(57.76%) | (71.65%) | (52.68%) | (59.97%) | |
Average Days of Receivables |
304.29 | 4.79 | — | — | |
Free Cash Flow per Share |
(2.39) | (2.34) | (2.25) | (2.44) | |
Free Cash Flow |
(449.99) | (437.46) | (419.23) | (422.10) | |
Capital Expenditures |
(5.80) | (3.42) | (6.89) | (9.50) | |
| Other line items | |||||
Cash ROIC |
(31.08%) | (28.20%) | (21.84%) | (22.37%) | |
Accounts Receivable Turnover |
1.90 | 152.28 | — | — | |
Accounts Payable Turnover |
0.38 | 1.13 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
1,295.80 | 335.71 | 0.00 | 0.00 | |
Days of Inventory on Hand |
2,485.20 | 117.69 | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,787.59% | 134.02% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
647.88% | 48.41% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
409.78% | 31.80% | 0.00% | 0.00% | |
Operating CF/Net income |
1.41 | 0.85 | 0.81 | 0.81 | |
Depreciation/Fixed assets |
0.16 | 0.12 | 0.08 | 0.02 | |
Capex/Depreciation |
(0.77) | (0.58) | (1.69) | (10.22) | |
Revenue per Share |
0.12 | 1.60 | 0.00 | 0.00 | |
Operating CF per Share |
(2.36) | (2.32) | (2.21) | (2.39) | |
Capex per Share |
(0.03) | (0.02) | (0.04) | (0.05) | |
Capex to Sales |
0.26 | 0.01 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026